Newron drops development of sarizotan in Rett syndrome
The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints
Read More
Tag: Newron
FDA OK’s first novel treatment for Parkinson’s in ten years
The US Food and Drug Administration has approved the first novel treatment option in more than a decade for patients with Parkinson’s disease experiencing ‘off’ episodes while being treated with levodopa/carbidopa.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
